What is the recommended duration for keeping gauze soaked with oxymetazoline (Afrin) and tranexamic acid (TXA) in the nose to control epistaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For epistaxis management using Afrin (oxymetazoline) and TXA (tranexamic acid) soaked gauze, keep the packing in place for approximately 15-30 minutes, as supported by the most recent and highest quality study 1.

Key Considerations

  • The combination of Afrin and TXA works effectively due to Afrin's vasoconstrictive properties and TXA's ability to inhibit fibrinolysis, creating a dual mechanism to stop bleeding.
  • After applying gentle pressure by pinching the soft part of the nose, the medicated gauze should remain until bleeding has stopped completely.
  • If bleeding persists after 30 minutes, medical attention should be sought.

Preparation and Application

  • Use standard gauze soaked in a combination of Afrin nasal spray and liquid TXA (typically 500 mg/5mL concentration).
  • Apply the medicated gauze to the affected nostril, ensuring it is in contact with the bleeding site.

Post-Removal Care

  • Avoid vigorous nose blowing, strenuous activity, and hot showers for 24 hours to prevent rebleeding.
  • Apply petroleum jelly to the inside of the nostrils to help prevent drying and further bleeding.

Evidence Summary

  • A 2025 study published in The American Journal of Emergency Medicine 1 compared the efficacy of oxymetazoline, tranexamic acid, and epinephrine-lidocaine combination in treating epistaxis, finding oxymetazoline to be superior in achieving rapid hemostasis.
  • Other studies, such as those published in 2021 2 and 2020 3, provide additional insights into the effectiveness of tranexamic acid and oxymetazoline in managing epistaxis, but the 2025 study 1 is the most recent and highest quality evidence available.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.